All Stories

  1. Vitamin D profile in autism spectrum disorder children and its relation to the disease severity
  2. Study of Cosavirus, Salivirus, and Bufavirus viruses in children with acute gastroenteritis
  3. Study of single nucleotide polymorphism of vascular endothelium factor in patients with differentiated thyroid cancer
  4. Micro RNA-23b as a potential biomarker in rheumatoid arthritis disease activity and severity: clinical, laboratory, and radiological cross-sectional study
  5. Molecular Detection of Sapovirus in Children Under Five Years with Acute Gastroenteritis in Mansoura, Egypt between January 2019 and February 2020
  6. Molecular Detection of Sapovirus in Children Under Five Years with Acute Gastroenteritis in Mansoura, Egypt between January 2019 and February 2020
  7. Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome
  8. Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome
  9. Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome
  10. Programmed death 1 (PD-1) serum level and gene expression in recent onset systemic lupus erythematosus patients
  11. Molecular study of sapovirus in acute gastroenteritis in children: a cross-sectional study
  12. CX3CR1 at V249M and T280M Gene Polymorphism and Its Potential Risk for End-Stage Renal Diseases in Egyptian Patients
  13. Study of Antibodies to Cytolethal Distending Toxin B (CdtB) and Antibodies to Vinculin in Patients with Irritable Bowel Syndrome
  14. Molecular study of sapovirus in acute gastroenteritis in children: a cross-sectional study
  15. Circulating micro RNA-223 and angiopoietin-like protein 8 as biomarkers of gestational diabetes mellitus
  16. Study of Plasmid Mediated Quinolone Resistance in Escherichia coli from Nosocomial Urinary Infections.
  17. Clinico-Pathological Study of Adenovirus Associated with Respiratory Infections in Children
  18. Can Triggering Receptors on Myeloid Cells be used for Diagnosis of Salmonella typhi Infection?
  19. Molecular Study of Norovirus in Pediatric Patients with Gastroenteritis
  20. Molecular detection and Frequency of Fluoroquinolone-Resistant Escherichia coli by Multiplex Allele Specific Polymerase Chain Reaction (MAS-PCR)
  21. Study of Hepatitis E Virus in Blood Donors
  22. Study of Antifungal Susceptibility, Virulence Genes and Biofilm Formation in Candida albicans
  23. Study of Various Virulence Genes, Biofilm Formation and Extended-Spectrum β-lactamase Resistance in Klebsiella pneumoniae Isolated from Urinary Tract Infections
  24. IL-6 −572G/C and −174G/C polymorphisms association with hepatitis C virus-induced hepatocellular carcinoma
  25. Association of 32-bp deletion polymorphism and promoter methylation of PTEN and hepatitis C virus induced hepatocellular carcinoma
  26. Molecular Study of Resistance of Staphylococcus aureus to Antiseptic Quaternary Ammonium Sulfate
  27. Molecular Study of Enterotoxins Genes of Isolated from Patients in Intensive Care Units
  28. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  29. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
  30. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40
  31. The Burden of Cardiovascular Diseases Among US States, 1990-2016
  32. Molecular Study of Quinolone Resistance Determining Regions of gyrA Gene and parC Genes in Clinical Isolates of Acintobacter baumannii Resistant to Fluoroquinolone
  33. Early detection of active Human Cytomegalovirus infection after living-donor liver transplantation
  34. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015
  35. Molecular study of colistin resistant clinical isolates of Enterobacteriaceae species
  36. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
  37. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  38. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015
  39. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  40. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  41. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  42. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  43. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  44. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  45. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
  46. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  47. Maternal mortality and morbidity burden in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study
  48. The burden of mental disorders in the Eastern Mediterranean region, 1990–2015: findings from the global burden of disease 2015 study
  49. Transport injuries and deaths in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 Study
  50. Burden of cancer in the Eastern Mediterranean Region, 2005–2015: findings from the Global Burden of Disease 2015 Study
  51. Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study
  52. Burden of lower respiratory infections in the Eastern Mediterranean Region between 1990 and 2015: findings from the Global Burden of Disease 2015 study
  53. Burden of vision loss in the Eastern Mediterranean region, 1990–2015: findings from the Global Burden of Disease 2015 study
  54. Danger ahead: the burden of diseases, injuries, and risk factors in the Eastern Mediterranean Region, 1990–2015
  55. Trends in HIV/AIDS morbidity and mortality in Eastern Mediterranean countries, 1990–2015: findings from the Global Burden of Disease 2015 study
  56. Burden of diarrhea in the Eastern Mediterranean Region, 1990–2015: Findings from the Global Burden of Disease 2015 study
  57. Evaluation of semi-nested polymerase chain reaction (PCR) and mannan antigen detection compared to blood culture for diagnosis of candidemia
  58. Molecular Study of Efflux Genes in Pseudomonas aeruginosa Isolated from Clinical Samples
  59. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  60. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
  61. Child and Adolescent Health From 1990 to 2015
  62. Kidney injury in infants and children with iron-deficiency anemia before and after iron treatment
  63. Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
  64. Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
  65. SP208EARLY DETECTION OF ACUTE KIDNEY INJURY IN CANCER PATIENTS RECEIVING PLATINUM BASED CHEMOTHERAPY
  66. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
  67. Global Cardiovascular and Renal Outcomes of Reduced GFR
  68. Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990–2013: findings from the Global Burden of Disease Study 2013
  69. Phenotypic Detection and Genotypic Characterization of Metallo-Beta-Lactamases in Gram Negative Bacilli isolated from Mansoura University Hospital in Egypt
  70. Molecular and Serological Study of Human Parvovirus B19 among Children with Thalassemia in Mansoura University Children Hospital, Egypt
  71. Seroprevalence of Helicobacter pylori and Chlamydia pneumoniae among Patients with Coronary Artery Diseases at Mansoura University Hospital, Egypt
  72. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
  73. Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after abdominal surgery
  74. Evaluation of Nested Polymerase Chain Reaction and Immunoassay for Rapid Diagnosis of Clostridium difficile in Children with Community Acquired Diarrhea
  75. Molecular Study of Acinetobacter baumannii Isolates for Metallo-β-Lactamases and Extended-Spectrum-β-Lactamases Genes in Intensive Care Unit, Mansoura University Hospital, Egypt
  76. Burden of Diarrhea in the Eastern Mediterranean Region, 1990–2013: Findings from the Global Burden of Disease Study 2013
  77. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
  78. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  79. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  80. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  81. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  82. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  83. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  84. Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  85. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  86. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
  87. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
  88. Homocysteine as a predictive biomarker in early diagnosis of renal failure susceptibility and prognostic diagnosis for end stages renal disease
  89. Value of immunoglobulin G avidity for primary cytomegalovirus diagnosis in pregnant women compared to nested polymerase chain reaction
  90. The Global Burden of Anemia
  91. Multiplex Polymerase Chain Reaction for Klebsiella pneumoniae Metallo-β-lactamase Causing Neonatal Sepsis in Mansoura Children University Hospital in Egypt
  92. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
  93. Study of Virulence Genes Cag A and Vac A in Helicobacter pylori Isolated from Mansoura University Hospital Patients by Multiplex PCR
  94. Molecular Study of Clarithromycin Resistant Helicobacter pylori strains from Egyptian Centre
  95. 10.1016/S0140-6736(15)60692-4
  96. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
  97. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  98. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  99. Ocular Chlamydia trachomatis in a tertiary hospital
  100. Non Hodgkin Lymphoma and Hepatitis C Virus in Egyptian Children: One Centre Study
  101. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  102. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  103. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  104. Maternal-Fetal Hepatitis E Transmission: Is It Underestimated?
  105. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt
  106. Evaluation of IgG Avidity for Diagnosis of AcuteToxoplasma gondiiCompared to Nested PCR in Pregnant Women in First Trimester
  107. Evaluation of New Media for Dermatophytes and non Dermatophytes Fungal Infections in diabetic patients
  108. Occult Hepatitis B among Patients under Hemodialysis at Mansoura University Hospitals: Prevalence and Risk Factors
  109. Pilot Study of Epstein Barr virus Infection at the Onset of Acute Lymphoblastic Leukaemia in Egyptian Children
  110. Study of interleukin 12-gamma interferon axis and natural killer cells in acute viral hepatitis
  111. Clinicolaboratory Study of Mother-to-Neonate Transmission of Hepatitis E Virus in Egypt
  112. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance
  113. P23: Role of innate immune response in acute viral hepatitis
  114. P46: Hepatitis E viral seroprevalence among multiple transfused Egyptian children
  115. Characteristics of hepatitis viruses among Egyptian children with acute hepatitis
  116. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt
  117. Post-Bacillus Calmette-Guérin lymphadenitis in Egyptian children
  118. High-Throughput Screening in Medical Diagnosis and Prognosis
  119. The high prevalence of Listeria monocytogenes peritonitis in cirrhotic patients of an Egyptian Medical Center
  120. Role of hepatitis E infection in acute on chronic liver failure in Egyptian patients
  121. Impact of anti‐oxidant status and apoptosis on the induction phase of chemotherapy in childhood acute lymphoblastic leukemia
  122. Evaluation of Interleukin-8 in Hepatitis C Virus Infection: Relation to Combined peg-interferon Ribavirin Response and Genotype 4
  123. DESCRIPTIVE EPIDEMIOLOGY OF HEMOPHILIA AND OTHER COAGULATION DISORDERS IN MANSOURA , EGYPT
  124. Risk factors and outcome of staphylococcus bloodstream infection in a paediatric hospital
  125. Clinical and hematological study for Parvovirus b19 infection in children with acute leukemia
  126. Correlation of Trichomonas vaginalis to bacterial vaginosis: a laboratory-based study
  127. Relevance of serology and molecular methods for detection of Hepatitis B virus in Egyptian children with hematological malignancy
  128. HLA Class I and Class II HLA DRB Profiles in Egyptian Children with Rheumatic Valvular Disease
  129. Long-term Immunogenicity of Hepatitis B Vaccination in children
  130. Study of Nitric Oxide in Patients with Chronic Hepatitis C Genotype 4: Relationship to Viremia and Response to Antiviral Therapy
  131. Study of human metapneumovirus-associated lower respiratory tract infections in Egyptian adults
  132. HUMAN METAPNEUMOVIRUS INFECTION IN ADULTS WITH LOWER RESPIRATORY TRACT INFECTIONS
  133. Value of hepatitis E virus detection by cell culture compared with nested PCR and serological studies by IgM and IgG
  134. Clinico-pathological study of atypical pathogens in community-acquired pneumonia: a prospective study
  135. Genital tract tuberculosis among infertile women: an old problem revisited
  136. Relevance of Serology for Mycoplasma pneumoniae Diagnosis Compared With PCR and Culture in Acute Exacerbation of Bronchial Asthma
  137. Parvovirus and herpes simplex association with unexplained anemia in pregnancy: a prospective study
  138. Clinical Significance of Serum Soluble Fas, Fas Ligand and Fas in Intrahepatic Lymphocytes in Chronic Hepatitis C
  139. Interleukin 8 Is a Surrogate Marker for Rapid Diagnosis of Bacteriuria
  140. Rapid Detection of Oculopathogenic Adenovirus in Conjunctivitis
  141. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB
  142. Diagnosis of Shiga toxin producing Escherichia coli infection, contribution of genetic amplification technique
  143. IL-18 Level Correlates with Development of Sepsis in Surgical Patients
  144. STUDY OF PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF MYCOBACTERIUM TUBERCULOSIS ISOLATES RESISTANT TO BOTH ISONIAZID AND ETHAMBUTOL
  145. Rapid Hybridization Probe Assay and PCR for Detection of Chlamydia trachomatis in Urinary Tract Infections: A Prospective Study
  146. Acute sporadic hepatitis E in children: diagnostic relevance of specific immunoglobulin M and immunoglobulin G compared with nested reverse transcriptase PCR
  147. DNA SEQUENCE ANALYSIS OF rpoB GENE MUTATIONS IN RIFAMPICIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS
  148. Extracellular accumulation of bioactive substances; Interleukin-1β (IL-1β) and plasminogen activator inhibitor-1 (PAI-1) in stored blood units and relation to bacterial contamination
  149. Parvovirus B19 infection in children with a variety of hematological disorders
  150. Evaluation of Herpes Simplex Detection in Corneal Scrapings by Three Molecular Methods
  151. Polymerase Chain Reaction of Pleural Biopsy Is a Rapid and Sensitive Method for the Diagnosis of Tuberculous Pleural Effusion